Drug Database
Back to search

Japan· JP-4291401A3090

シスプラチン

A cisplatin product containing シスプラチン, registered in Japan by 日本化薬, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

On Japan’s NHI price listATC L01XA01

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedシスプラチンATCL01XA01REGISTER NO.JP-4291401A3090PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about シスプラチンAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cisplatin is registered in 16 of 19 countries.

Countries holding a registration under ATC L01XA01 (cisplatin), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 8 of them publish a price we can compare per daily dose
Search cisplatin products by name

Cisplatin · ATC L01XA01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
シスプラチン
Manufacturer
日本化薬
Country
Japan (JP)
ATC code
L01XA01
ATC class
Cisplatin
Defined daily dose
6.75 mg, P
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

593 interactions on record for cisplatin.

Graded by severity as the source publishes them — 65 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cisplatin against other medicinesHow interaction checks work

Cisplatin · interactions on record

593 records

  • 65 severe
  • 252 moderate
  • 20 minor
  • 256 info

Most severe, free to view

  • AmiodaroneC01BD01severe
  • DofetilideC01BD04severe
  • DronedaroneC01BD07severe
  • EtelcalcetideH05BX04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cisplatin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cisplatin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Cisplatin Accord, Cisplatin Ebewe
  • Belgium · Cisplatin Accord Healthcare, Cisplatine Teva
  • Bulgaria · Цисплатин Акорд, Цисплатин Ебеве
  • Cyprus · Cisplatin Accord Healthcare, Cisplatin Pfizer Hellas
  • Czechia · Cisplatin Ebewe
  • Germany · Cisplatin Accord, Cisplatin Hikma
  • Denmark · Cisplatin "ebewe", Cisplatin Accord
  • Estonia · Cisplatin Accord
  • Spain · Cisplatino Accord, Cisplatino Hikma
  • Finland · Cisplatin Accord, Cisplatin Ebewe
  • France · Cisplatine Accord, Cisplatine Hikma
  • United Kingdom (Northern Ireland) · Cisplatin, Cisplatin Accord Healthcare
  • Greece · Cisplatin Hospira, Oncoplat
  • Croatia · Cisplatin Pliva, Cisplatin Pontus
  • Hungary · Cisplatin Accord, Cisplatin Sandoz
  • Ireland · Cisplatin Accord Healthcare Ireland, Cisplatin Pfizer Healthcare Ireland
  • Italy · Cisplatin Teva, Cisplatino Accord Healthcare Italia
  • Lithuania · Cisplatin Accord
  • Luxembourg · Cisplatine Teva
  • Latvia · Cisplatin Accord
  • Malta · Cisplatin Accord Healthcare
  • Netherlands · Cisplatine Accord, Cisplatine Hikma
  • Norway · Cisplatin Accord
  • Poland · Cisplatin Ebewe, Cisplatinum Accord
  • Portugal · Cisplatina Accord, Cisplatina Hikma
  • Romania · Cisplatină Accord
  • Sweden · Cisplatin Accord, Cisplatin Ebewe
  • Slovenia · Cisplatin Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8435098a-7e8f-451c-8252-b2aac70a4155
GET /v1/drugs/8435098a-7e8f-451c-8252-b2aac70a4155?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "５０ｍｇ１００ｍＬ１瓶",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "4291401A3090",
  "category": "注射薬",
  "price_yen": 2991,
  "generic_name": "シスプラチン",
  "product_name_jp": null,
  "therapeutic_class": "4291",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about cisplatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console